Here we show tolvaptan, a vasopressin V2 receptor antagonist, which is prescribed for patients with ADPKD to slow renal cyst progression (15, 56), can suppress the formation of dilated pronephric tubules observed in xCEP290-depleted kidneys of Xenopus embryos. This evidence concerns the gene AVPR2 and autosomal dominant polycystic kidney disease.